Carbon Monoxide

Carbon Monoxide

SCHEMBL9987491

Cl[Re].[C]=O.[C]=O.[C]=O.c1ccc(SCCCSc2ccccc2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
MAPK1 P28482 1/20 0.58
CYP1A2 P05177 4/20 0.49
CYP2D6 P10635 4/20 0.49
CYP2C19 P33261 4/20 0.49
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
FFAR1 O14842 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbon Monoxide SCHEMBL9988779 0.91 ALDH1A1 (0.71) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
Formaldehyde SCHEMBL14837510 0.89 ALDH1A1 (0.62) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL1931125 0.86 ALDH1A1 (0.78) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL420011 0.81 ALDH1A1 (0.78) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL5167895 0.79 ALDH1A1 (0.74) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL5169003 0.79 ALDH1A1 (0.74) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL955977 0.77 ALDH1A1 (0.64) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL95856 0.77 ALDH1A1 (0.64) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL25918085 0.76 ALDH1A1 (0.61) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL3394436 0.76 ALDH1A1 (0.61) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987491-B2 Rhenium complexes and their pharmaceutical use SOCIETE DE COORDINATION DE RECHERCHES THERAPEUTIQUES (FR) 2015-03-24 US disclosed
EP-2575800-B1 RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE. COORDINATION DE RECH S THERAPEUTIQUES SOC D (FR) 2015-01-14 EP disclosed
US-20130158109-A1 RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-06-20 US disclosed
EP-2392324-A1 Rhenium complexes and their pharmaceutical use SOCIETE DE COORDINATION DE RECHERCHES THERAPEUTIQUES (FR) 2011-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158109-A1 RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE REN, PKD1, KRAS ALDH1A1 3976/4885MAPK1 1478/4885CYP1A2 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.